Skip to main content
Top
Published in: Clinical Rheumatology 2/2016

01-02-2016 | Brief Report

Power of national economy, disease control and employment status in patients with RA—an analytical multi-site ecological study

Authors: Herwig Pieringer, Rudolf Puchner, Erich Pohanka, Kathrin Danninger

Published in: Clinical Rheumatology | Issue 2/2016

Login to get access

Abstract

In rheumatology, sufficient disease control is a central part of the treatment concept. However, modern treatment strategies are associated with a substantial economic burden for health care systems. Ecological studies offer the unique opportunity to analyse differences between groups as well as group level effects. In the present analytical multi-site ecological study, we investigated whether more powerful national economies as measured by the gross domestic product per capita (GDPpc) are associated with better disease control in RA patients as measured by the disease activity score 28 (DAS28). We used aggregated data on RA patients from the recently published COMORA study as well as the World Health Organization database. There was a strong negative correlation between DAS28 and GDPpc (r = −0.815; p = 0.0002). Adjustment for sex, smoking status, disease duration or current employment status did not significantly change this association. There was a strong, negative correlation between DAS28 and age (r = −0.870; p < 0.001) and a strong, positive correlation between GDPpc and age (r = 0.737; p = 0.002). Adjustment for age reduced the regression coefficient (DAS28/GDPpc) to −0.000018 (p = 0.054). There was a negative correlation between DAS28 and current employment status (r = −0.642; p = 0.008) and a positive correlation between GDPpc and employment status (r = 0.722; p = 0.002). In conclusion, there is evidence of an association between disease control and GDPpc. This association is alleviated after adjustment for age. Of note, in countries with higher GDPpc, a higher proportion of RA patients are currently employed. This is true despite the fact that RA patients in countries with higher GDPpc are also older.
Literature
1.
go back to reference Symmons DPM (2005) Looking back: rheumatoid arthritis—aetiology, occurrence and mortality. Rheumatology (Oxford) 44(Suppl 4):iv14–iv17 Symmons DPM (2005) Looking back: rheumatoid arthritis—aetiology, occurrence and mortality. Rheumatology (Oxford) 44(Suppl 4):iv14–iv17
2.
go back to reference Machold KP, Stamm TA, Nell VPK et al (2007) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiograph progression over the first years of disease. Rheumatology (Oxford) 46:342–9CrossRef Machold KP, Stamm TA, Nell VPK et al (2007) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiograph progression over the first years of disease. Rheumatology (Oxford) 46:342–9CrossRef
3.
go back to reference Fuchs HA, Kaye JJ, Callahan LF, Nance EP (1989) Pincus T evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16(5):585–91PubMed Fuchs HA, Kaye JJ, Callahan LF, Nance EP (1989) Pincus T evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16(5):585–91PubMed
4.
go back to reference Aletaha D, Smolen J (2005) The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100PubMed Aletaha D, Smolen J (2005) The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100PubMed
5.
go back to reference Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, T2T Expert Committee (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631–637PubMedCentralCrossRefPubMed Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, T2T Expert Committee (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631–637PubMedCentralCrossRefPubMed
6.
go back to reference Smolen JS (2012) Treat-to-target: rationale and strategies. Clin Exp Rheumatol 30:S2–S6PubMed Smolen JS (2012) Treat-to-target: rationale and strategies. Clin Exp Rheumatol 30:S2–S6PubMed
7.
go back to reference Kievit W, Fransen J, de Waal Malefijt MC, den Broeder AA, van Riel PL (2013) Treatment changes and improved outcomes in RA: an overview of a large inception cohort from 1989 to 2009. Rheumatology (Oxford) 52:1500–8CrossRef Kievit W, Fransen J, de Waal Malefijt MC, den Broeder AA, van Riel PL (2013) Treatment changes and improved outcomes in RA: an overview of a large inception cohort from 1989 to 2009. Rheumatology (Oxford) 52:1500–8CrossRef
8.
go back to reference Aga AB, Lie E, Uhlig T, Olsen IC, Wierød A, Kalstad S, Rødevand E, Mikkelsen K, Kvien TK, Haavardsholm EA (2015) Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010. Ann Rheum Dis 74:381–8CrossRefPubMed Aga AB, Lie E, Uhlig T, Olsen IC, Wierød A, Kalstad S, Rødevand E, Mikkelsen K, Kvien TK, Haavardsholm EA (2015) Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010. Ann Rheum Dis 74:381–8CrossRefPubMed
9.
go back to reference Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A (2010) Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the national database of the German collaborative arthritis centres. Ann Rheum Dis 69:1803–8CrossRefPubMed Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A (2010) Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the national database of the German collaborative arthritis centres. Ann Rheum Dis 69:1803–8CrossRefPubMed
10.
go back to reference Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A (2006) Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 65:1175–1183PubMedCentralCrossRefPubMed Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A (2006) Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 65:1175–1183PubMedCentralCrossRefPubMed
11.
go back to reference Huscher D, Mittendorf T, von Hinüber U, Kötter I, Hoese G, Pfäfflin A, Bischoff S, Zink A; for the German Collaborative Arthritis Centres (2014) Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis. Jan 9 Huscher D, Mittendorf T, von Hinüber U, Kötter I, Hoese G, Pfäfflin A, Bischoff S, Zink A; for the German Collaborative Arthritis Centres (2014) Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis. Jan 9
12.
go back to reference Hennekens CH, Buring JA (1987) Epidemiology in medicine. Lippincott Williams & Wilkins Hennekens CH, Buring JA (1987) Epidemiology in medicine. Lippincott Williams & Wilkins
13.
go back to reference Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH et al (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62–8PubMedCentralCrossRefPubMed Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH et al (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62–8PubMedCentralCrossRefPubMed
14.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24CrossRefPubMed
15.
go back to reference Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–8CrossRefPubMed Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–8CrossRefPubMed
16.
go back to reference Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD (2001) Healthy life expectancy in 191 countries, 1999. World Health Report 2000. Lancet 357:1685–81CrossRefPubMed Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD (2001) Healthy life expectancy in 191 countries, 1999. World Health Report 2000. Lancet 357:1685–81CrossRefPubMed
17.
go back to reference Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM 104:13–26CrossRefPubMed Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM 104:13–26CrossRefPubMed
Metadata
Title
Power of national economy, disease control and employment status in patients with RA—an analytical multi-site ecological study
Authors
Herwig Pieringer
Rudolf Puchner
Erich Pohanka
Kathrin Danninger
Publication date
01-02-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2918-x

Other articles of this Issue 2/2016

Clinical Rheumatology 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.